EMMAC: Curaleaf to Enter European Cannabis Market with Acquisition of EMMAC Life Sciences Limited - Europe's Leading Independent Cannabis Company

EMMAC Brings the Largest Vertically Integrated Independent Cannabis Company in Europe with a Presence in Key European Medical Cannabis Markets, Including the United Kingdom, Germany, Italy, Spain, and Portugal With the European Population of Nearly 748 Million(1), the Potential Addressable Market is More than Twice the Size of U.S. Market WAKEFIELD, Mass., March 9, 2021 /CNW/ - Curaleaf [...]The post Curaleaf to Enter European Cannabis Market with Acquisition of EMMAC Life Sciences Limited - Europe's Leading Independent Cannabis Company appeared first on CannabisFN.